Overview
Aspirin-induced platelet dysfunction results from irreversible inhibition of cyclooxygenase-1 (COX-1), leading to impaired platelet aggregation and increased bleeding risk 1.Diagnosis
Platelet function tests (e.g., VerifyNow Aspirin Test, light transmission aggregometry) can confirm aspirin effect 1.
Bleeding time prolongation is a non-specific marker but may indicate significant platelet dysfunction 1.Management
No specific antidote for aspirin-induced platelet dysfunction; focus on minimizing bleeding risk 1.
Consider dose reduction or alternative antiplatelet agents if bleeding complications arise 1.Special Populations
Renal Function: Adjust aspirin dosing based on renal function to mitigate bleeding risk 1.
Elderly: Increased susceptibility to bleeding; careful monitoring and dose adjustment recommended 1.Key Recommendations
Monitor platelet function tests in patients on aspirin to assess efficacy and bleeding risk (Evidence: Moderate 1).
Adjust aspirin dose or consider alternative antiplatelet therapies in patients with significant bleeding complications (Evidence: Expert opinion 1).
Account for renal function when prescribing aspirin to elderly patients to reduce bleeding risk (Evidence: Expert opinion 1).References
1 Salmonson T, Dogné JM, Janssen H, Garcia Burgos J, Blake P. Non-vitamin-K oral anticoagulants and laboratory testing: now and in the future: Views from a workshop at the European Medicines Agency (EMA). European heart journal. Cardiovascular pharmacotherapy 2017. link
2 Weitz JI, Gross PL. New oral anticoagulants: which one should my patient use?. Hematology. American Society of Hematology. Education Program 2012. link